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In 2003 theWorldHealth Organization (WHO) convened aworking group and published a set of standard
methods for studies measuring nasopharyngeal carriage of Streptococcus pneumoniae (the pneumococ-
cus). The working group recently reconvened under the auspices of the WHO and updated the consensus
standard methods. These methods describe the collection, transport and storage of nasopharyngeal sam-
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arriage
olonization
neumococcus
culture and non-culture based
the evidence supporting this p
carriage studies. Adherence to
carriage studies undertaken in
epidemiology studies more gen
of study ﬁndings.
∗ Corresponding author at: Pneumococcal Research, Murdoch Childrens Research Instit
E-mail address: catherine.satzke@mcri.edu.au (C. Satzke).
1 WHO Pneumococcal Carriage Working Group were participants at the Geneva meetin
SA; Bernard Beall, Centers for Disease Control and Prevention, USA; Ron Dagan; Ben-Gur
irgitta Henriques-Normark, Karolinska Institutet, MTC and Karolinska University Hospi
NG and Monash University Gippsland Campus, Victoria, Australia; Jennifer Moïsi and B
aranhos-Baccala, FondationMerieux, France; KarenRudolph, Centers forDisease Control
uba; Didrik Vestrheim, Norwegian Institute of Public Health, Norway; Jeffrey Weiser, Pe
264-410X © 2013 Elsevier Ltd.
ttp://dx.doi.org/10.1016/j.vaccine.2013.08.062
Open access under CC BY-NC-ND license.approaches. We outline the consensus position of the working group,
osition, areas worthy of future research, and the epidemiological role of
these methods will reduce variability in the conduct of pneumococcal
the context of pneumococcal vaccine trials, implementation studies, and
erally so variability in methodology does not confound the interpretation
© 2013 Elsevier Ltd.
ute, Royal Children’s Hospital, Parkville, 3052, VIC, Australia. Tel.: +61 3 8341 6438.
g in March 2012 and included the authors listed above and Mark Alderson, PATH,
ion University of the Negev, Israel; David Goldblatt, University College London, UK;
tal, Sweden; Andrew Greenhill; Papua New Guinea Institute of Medical Research,
erthe Njanpop, Agence de Médecine Préventive, Institut Pasteur, France; Glaucia
and Prevention, Alaska; VicenteVerez Bencomo, Centre for Biomolecular Chemistry,
relman School of Medicine, University of Pennsylvania, USA.
Open access under CC BY-NC-ND license.
1 ccine 3
1
c
w
s
m
e
n
g
c
a
w
c
t
C
r
i
P
r
p
s
T
d
b
p
h
h
p
t
s
t
i
l
i
p
k
l
t
n
d
T
t
T
a
r
s
2
r
W
y
s
(
s
a
O
S
W66 C. Satzke et al. / Va
. Introduction
Between1998 and2001 theWorldHealthOrganization (WHO1)
onvened the Pneumococcal Carriage Working Group. This group
as charged with formulating a set of core methods for conducting
tudies of pneumococcal nasopharyngeal (NP) colonization pri-
arily in the context of pneumococcal conjugate vaccine (PCV)
fﬁcacy trials [1]. The PCV efﬁcacy trials led to PCV licensure and
ow widespread inclusion of PCV in routine immunization pro-
rams around the world. Numerous studies of PCV effect on NP
olonization were published in the pre-licensure period and were
vailable for consideration by regulators, although no indication
as sought for this outcome. PCV impact studies have also included
arriage components, thereby providing important lessons about
he performance and impact of PCV on a population level [2–4].
arriage studies have provided the key biological link to the indi-
ect effect of PCV on pneumococcal disease [2], shown that there
s no change in the invasiveness of pneumococcal strains since
CV implementation [2,3], anticipated the impact of PCV on cross-
eacting serotypes [2,5,6], contributed to the identiﬁcation of new
neumococcal serotypes [7,8], and have been central to our under-
tanding of antimicrobial resistance evolution and impact [9,10].
hevariability in results frompneumococcal carriage studies across
iverse epidemiologic settings can be understood to derive from
iologic effects rather than methodological differences, in large
art becausemanyof the standardpneumococcal carriagemethods
ave been widely adopted.
In the decade since last convening the working group there
ave been many key accomplishments including sequencing of 90
neumococcal capsular loci [11], the advent of molecular detec-
ion and quantiﬁcation of pneumococci in NP specimens and
erotype-speciﬁc detection including improved detection of mul-
iple serotype colonization. There have been signiﬁcant advances
n molecular typing, and in modeling and statistical methods for
ongitudinal studies of carriage dynamics.
In light of these advances, and the importance of carriage stud-
es, WHO invited an ad hoc group of experts, some of whom
articipated in the previous working group, to evaluate the state of
nowledge, revise the core methods where appropriate, and out-
ine the important scientiﬁc questions for the future. In developing
his update, the authors reviewed newly published literature perti-
ent to each aspect of the consensus method, sought unpublished
ata on relevant issues and wrote a set of draft recommendations.
his document was circulated to the working group and formed
he basis of a review meeting in Geneva, 29–30th March 2012.
he resultant consensus methods were then circulated for ﬁnal
pproval. Our recommendations, outlined in detail below, provide
esearchers with a set of methods that we believe are a minimum
et of requirements for pneumococcal carriage studies.
. Site of sample
It is possible to detect microbial colonization of the upper respi-
atory tract by sampling the nose, nasopharynx or the oropharynx.
e considered the choice between the nasopharynx and orophar-
nx for detecting pneumococcal carriage (the sensitivity of nasal
ampling is covered in Section 3). We have identiﬁed nine studies
including one unpublished) that have compared the sensitivity of
ampling the nasopharynx and oropharynx of children (Table 1),
nd ﬁve studies for adults (Table 2). It was not possible to extract
1 Abbreviations: CI, conﬁdence interval; NP, nasopharyngeal; OP, oropharyngeal;
TU, operational taxonomic unit; PCV, pneumococcal conjugate vaccine; STGG,
kim milk tryptone-glucose-glycerol; ULT, ultra-low temperature, ≤−70 ◦C; WHO,
orld Health Organization.2 (2014) 165–179
paired information from all studies, sowe compared the sensitivity
of NP or oropharyngeal (OP) swabs alone in the detection of pneu-
mococcal carriage against a gold standard of detection by either
method when both were sampled in an individual. We restricted
our review to studies published from1975onwards, as prior to this,
swabs were often collected with rigid wooden applicators, which
were assumed to be less effective when sampling via the nose than
when passed via the mouth.
In children, the additional yield provided by sampling the
oropharynx as well as the nasopharynx is relatively small, as the
sensitivity of sampling the nasopharynx alone is >90% in seven of
nine studies and <80% in only one small study (Table 1). In adults,
the advantage to theNP route is not somarked and an ideal strategy
involves sampling by both routes (Table 2). Data relating to detec-
tion ofHaemophilus inﬂuenzae,Moraxella catarrhalis, Staphylococcus
aureus and respiratory viruses from different sites are described in
the Supplementary Material (including Supplementary Table 1).
2.1. Recommendation
For detecting pneumococci in infants and children, we recom-
mend sampling the nasopharynx only. Sampling the oropharynx
marginally increases sensitivity but substantially increases the
resources required, andmay not be acceptable to the study popula-
tion. For adults, both NP and OP samples should be collected, how-
ever if only one sample is possible, collecting from the nasopharynx
is more sensitive than from the oropharynx for pneumococci.
2.2. Future research
All studies reviewed here used culture to detect respiratory
bacteria. Therefore molecular testing of paired NP/OP samples
is needed to establish if the recommendations for anatomic site
of sampling apply also to studies using molecular detection of
pneumococci.
3. NP and nasal sample collection
Conventional teaching is that nasal specimens are less sensitive
than NP samples for detecting pneumococci. We identiﬁed only
three studies directly comparing NP and nasal sampling methods
for detecting pneumococci in children (Supplementary Table 2).
Rapola et al. [12] found that pneumococcal isolation rates from NP
aspirates, NP swabs and nasal swabs did not differ. The same con-
clusionwas reached by Carville et al. [13] for NP aspirates and nasal
swabs, and Van den Bergh et al. [14] for NP swabs and nasal swabs.
However, in two of these studies children had respiratory symp-
toms, either acute respiratory infection [12] or rhinorrhea [14],
conditions that are known to enhance pneumococcal carriage and
possibly affect the sensitivity of detection from nasal specimens.
As such, there is currently insufﬁcient evidence to conclude that
nasal swabbing is as effective as NP swabbing for the detection of
pneumococcal carriage in healthy children. A fourth comparative
study [15] found that NP washes performed better than NP swabs,
but concluded that the additional gain was not sufﬁciently large to
offset the discomfort and reduced acceptability to study subjects.
Lieberman et al. [16] andGritzfeld et al. [17] found no difference
between NP swabs and NP or nasal washes for the detection of
pneumococci in adults with respiratory infection (Supplementary
Table 2). The adults found nasal washes more comfortable than NP
swabbing, but nasal washes were not recommended for children
because of the level of participant cooperation required [17].There are potential disadvantages of nasal/NP aspirates and
washes for pneumococcal detection; the methods are difﬁcult to
standardize, and frequent washes in an individual hypothetically
may disrupt the ﬂora or affect immune responses. Given that nasal
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Table 1
Sensitivity of sampling the nasopharynx or oropharynx for detecting pneumococcal carriage in infants and children.
Study [ref] Year Study details No. positive
samples (NP)a
No. positive
samples (OP)a
No. positive
samples (NP or OP)
Sensitivityb of NP
samples (95% CI)
Sensitivityb of OP
samples (95% CI)
Hendley et al. [1] 1975 27 healthy
American children
8 13 14 57% (29, 82) 93% (66, 100)
Converse and
Dillon [2]
1977 Longitudinal study
of 100 healthy
American infants,
132 paired swabs
55 51 58 95% (86, 99) 88% (77, 95)
Gray et al. [3] 1980 Longitudinal study
of 82 healthy
American children
aged <2 years
456 394 476 96% (94, 97) 83% (79, 86)
Capeding et al. [4] 1995 Longitudinal study
of 296 healthy
Filipino infants
aged 6–65 weeks
607c 222 639 95% (93, 97) 35% (31, 39)
Rapola et al. [5] 1997 96 Finnish children
aged <7 years with
acute respiratory
infection
29 19 32d 91% (75, 98) 59% (41, 76)
Greenberg et al. [6] 2004 216 healthy Israeli
children aged <5
years
144 36 147 98% (94, 100) 24% (18, 32)
Taylor et al. [7] 2006 47 Canadian
children with
Cystic Fibrosis
12e 0 12 100% (74, 100) 0% (0, 26)
Katz et al. [8] 2007 125 healthy
Russian children
63 39 75 84% (74, 91) 52% (40, 64)
Hare et al.
(unpublished
data)
2013 120 Australian
Aboriginal children
with bronchiectasis
43 7 44 98% (93, 100) 16% (5, 27)
References: [1] Hendley JO, Sande MA, Stewart PM, Gwaltney JM, Jr. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis.
1975;132:55-61. [2] Converse GM, 3rd, Dillon HC, Jr. Epidemiological studies of Streptococcus pneumoniae in infants: methods of isolating pneumococci. J Clin Microbiol.
1977;5:293-6. [3] Gray BM, Converse GM, 3rd, Dillon HC, Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the
ﬁrst 24 months of life. J Infect Dis. 1980;142:923-33. [4] Capeding MR, Nohynek H, Sombrero LT, Pascual LG, Sunico ES, Esparar GA, et al. Evaluation of sampling sites
for detection of upper respiratory tract carriage of Streptococcus pneumoniae and Haemophilus inﬂuenzae among healthy Filipino infants. J Clin Microbiol. 1995;33:3077-9.
[5] Rapola S, Salo E, Kiiski P, Leinonen M, Takala AK. Comparison of four different sampling methods for detecting pharyngeal carriage of Streptococcus pneumoniae and
Haemophilus inﬂuenzae in children. J Clin Microbiol. 1997;35:1077-9. [6] Greenberg D, Broides A, Blancovich I, Peled N, Givon-Lavi N, Dagan R. Relative importance of
nasopharyngeal versus oropharyngeal sampling for isolation of Streptococcus pneumoniae and Haemophilus inﬂuenzae from healthy and sick individuals varies with age. J
Clin Microbiol. 2004;42:4604-9. [7] Taylor L, Corey M, Matlow A, Sweezey NB, Ratjen F. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-
producing patientswith cystic ﬁbrosis. Pediatr Pulmonol. 2006;41:839-43. [8] Katz A, Leibovitz E, Timchenko VN, Greenberg D, Porat N, Peled N, et al. Antibiotic susceptibility,
serotype distribution and vaccine coverage of nasopharyngeal and oropharyngeal Streptococcus pneumoniae in a day-care centre in St. Petersburg, Russia. Scand J Infect Dis.
2007;39:293-8.
a The nasopharynx and oropharynx were sampled by swab unless otherwise indicated.
b Sensitivities were estimated against a gold standard of ‘positive in either sample’ using the data presented in the published ﬁndings.
c This study used nasal swabs taken from the nostrils with a cotton-tipped wooden applicator.
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r NP washing is generally less well tolerated by children, a single
P swab is preferred for the detection of pneumococcal carriage
ut washes/aspirates are an acceptable method [15].
NP swabbing techniques may vary across studies unless the
nvestigators adhere closely to the standard method, summarized
ere. Hold the infant or young child’s head securely. Tip their head
ackwards slightly and pass the swab directly backwards, paral-
el to the base of the NP passage. The swab should move without
esistance until reaching the nasopharynx, located about one-half
o two-thirds the distance from the nostril to ear lobe (Fig. 1).d standard.
If resistance occurs, remove the swab and attempt again to take
the sample entering through the same or the other nostril. Fail-
ure to obtain a satisfactory specimen is often due to the swab
not being fully passed into the nasopharynx. Once the swab is in
location, rotate the swab 180◦, or leave in place for 5 s to satu-
rate the swab tip; remove the swab slowly. All swabs should be
processed; however, to assist with interpreting the results, inves-
tigators should record whether the procedure was acceptable or
suboptimal. Recording if secretions are present on the swab [18]
and whether the swab was potentially contaminated (e.g. touched
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Table 2
Sensitivity of nasopharyngeal (NP) or oropharyngeal (OP) sampling for detecting pneumococcal carriage in adults.
Study [ref] Year Study details No. positive
samples (NP)a
No. positive
samples (OP)a
No. positive
samples (NP or OP)
Sensitivityb of NP
samples (95% CI)
Sensitivityb of OP
samples (95% CI)
Hendley et al. [1] 1975 24 healthy
American adults
0 9 9 0% (0, 34) 100% (66,100)
Greenberg et al. [2] 2004 216 Israeli mothers
of young children
19 18 33 58% (39, 75) 55% (36, 72)
Watt et al. [3] 2004 1994 Native
American adults
222 115 304 73% (68, 78) 38% (32, 44)
Lieberman et al. [4] 2006 300 Israeli adults
with respiratory
infection
29 13 36 81% (64, 92) 36% (21, 54)
Levine et al. [5] 2012 742 Israeli army
recruits
31 27 49 63% (48, 77) 55% (40, 69)
References: [1] Hendley JO, Sande MA, Stewart PM, Gwaltney JM, Jr. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis.
1975;132:55-61. [2] Greenberg D, Broides A, Blancovich I, Peled N, Givon-Lavi N, Dagan R. Relative importance of nasopharyngeal versus oropharyngeal sampling for isolation
of Streptococcus pneumoniae and Haemophilus inﬂuenzae from healthy and sick individuals varies with age. J Clin Microbiol. 2004;42:4604-9. [3] Watt JP, O’Brien KL, Katz S,
Bronsdon MA, Elliott J, Dallas J, et al. Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adults. J Clin Microbiol. 2004;42:4974-6. [4]
Lieberman D, Shleyfer E, Castel H, Terry A, Harman-Boehm I, Delgado J, et al. Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens
in adults. J Clin Microbiol. 2006;44:525-8. [5] Levine H, Zarka S, Dagan R, Sela T, Rozhavski V, Cohen DI, et al. Transmission of Streptococcus pneumoniae in adults may occur
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a The nasopharynx and oropharynx were sampled by swab unless otherwise indi
b Sensitivities were estimated against a gold standard of ‘positive in either sampl
y the investigator ordroppedon theground)mayalsobehelpful in
nterpretation.
Because NP specimen collection (by swab or by wash) requires
raining, demands adherence to the methodology, and is unpleas-
nt for the study subject, and because sometimes even nasal swabs
re not well tolerated, alternate methods have been assessed.
each et al. [19] found that in an Australian population with a
igh pneumococcal burden, nose blowing into a paper tissue, fol-
owed by swabbing and culture of the material on the tissue, was
n effective alternative to nasal swabbing when nasal secretions
ere present. The sensitivity of detecting pneumococcus fromnose
lowing samples (compared with nasal swabs, and when secreti-
ns were visible at the time of sampling) was 97% in Aboriginal
hildren aged 3–7 years and 94% in children aged less than 4 years
ho were attending urban child care centers. For children with-
ut visible secretions, direct NP or nasal sampling was required
19]. Recently, Van den Bergh et al. [14] found that the propor-
ion of pneumococcal-positive cultureswas similarwhen sampling
ecretions froma tissue (tissue swab 65%,whole tissue 74%), or tak-
ng NP and nasal swabs (both 64%) in 66 Dutch children aged 0–4
earswith rhinorrhea. Data relating to detection ofH. inﬂuenzae,M.
atarrhalis, S. aureus and respiratory viruses by various sampling
ethods are described in the Supplementary Material (including
upplementary Table 3).Fig. 1. Collecting a nasopharyngeal swab..
g the data presented in the published ﬁndings.
3.1. Recommendation
We recommend the NP swab approach for collection of the
sample. NP aspirates or washes are also acceptable methods of
specimen collection as they have sensitivity for pneumococcal
detection equal to, or greater than, that of NP swabs, but may be
less tolerated by participants. In the event that NP sampling can-
not be implemented, nasal swabs or swabbing visible secretions
from nose blowing into a tissue are better than collecting no spec-
imens. However, any deviation from the recommended NP swab
should be clearly reported to allow accurate comparisons across
studies.
3.2. Future research
All data presented are from studies using culture to detect
pneumococci. Specimen collection comparison studies should be
undertaken using molecular methods for pneumococcal detection.
Direct comparisons of NP and nasal sampling methods in healthy
children are also needed.
4. Number of NP specimens
A single NP swab is unlikely to represent the colonizing bacteria
of the upper respiratory tract with complete sensitivity, as these
bacteria may not reside uniformly across the mucosal surface, and
there is inherent variability in the mucosal surfaces touched by
each sample swab. The insensitivity of a single swab has been
demonstrated by studies that have sampled the upper respiratory
tract twice at the same visit, usually by taking one swab from the
nasopharynx and another from the oropharynx (Tables 1 and 2).
This prompts two questions: what is the sensitivity of a single
NP swab and could this sensitivity be optimized by increasing the
number of swabs collected?
The sensitivity of a single swab has been estimated using NP
wash as a gold standard among healthy Kenyan children [15]. NP
swabs had sensitivity of 85% (95%CI 73–95%)whenboth a swab and
wash were collected in immediate sequence. In all children with a
negative NP wash, the NP swab was also negative. Furthermore,
two NP swabs (one swab passed into each nostril a few minutes
apart) were found to be only marginally superior to a single NP
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wab. Taking the combined positive results of the two swabs as
reference gold standard, the sensitivity of a single swab was 95%
95% CIs 88–98%). Therewas no evidence of a systematic advantage
o swabbing either the right or left nostril [15].
.1. Recommendation
Increasing the number of NP swabs taken at the same time-
oint does not increase the sensitivity appreciably, but increases
he discomfort to the subject. Therefore, we recommend collecting
single NP swab to detect pneumococcal carriage.
.2. Future research
The study cited for this recommendation used culture-based
etection andwas conﬁned to a single setting. Additional studies of
ultiple swabs would contribute meaningfully to the evidence for
his recommendation if conducted among children in low preva-
ence settings, among adults, and/or including molecular methods
f detection.
. Swab material
Ideally, NP swabs used for colonization studies should (1) be
afe for usewithminimal irritation or side effects, (2) be efﬁcient at
xtracting micro-organisms from the nasopharynx onto the swab,
3) have no effect on the viability of the isolated pneumococci or
ny other pathogens (viral or bacterial) to be assayed, (4) alloweasy
lution of organisms from the swab and (5) be compatible with all
ntended assays. For example, calcium alginate inhibits some real-
ime PCR assays resulting in a reduced sensitivity of detection of
ordetella pertussis [20], andnatural ﬁbers (e.g. cotton, rayon, or cal-
ium alginate) often contain nucleic acids, which may be detected
n whole microbiome sequencing studies (D. Bogaert, unpublished
ata) or may include inhibitors to pneumococcal growth (e.g. cot-
on).
Materials that have been widely used in pneumococcal NP clin-
cal studies include calcium alginate, rayon, Dacron and nylon
ocked swabs. There are no clinical studies comparing the per-
ormance of these materials head-to-head, so any distinctions, if
hey exist, are inferred from studies of spiked samples and cross
tudy clinical comparisons. Rayon, Dacron and calcium alginate
wabs were compared for their ability to culture pneumococci
irectly fromthe swabor fromthe surrounding skimmilk tryptone-
lucose-glycerol (STGG) medium [21]. Rayon was shown to be
uperior for culture from both the STGG medium and the swab,
ollowed by calcium alginate and then Dacron. By contrast, Dube
t al. found Dacron was superior to rayon in efﬁciency of pneu-
ococcal elution from the swab into STGG (eluting approximately
4% vs. 8% of the inoculum respectively), and that nylon ﬂocked
wabs (eluting 100% of the inoculum) were the most efﬁcient [22].
ollectively these data, alongwith the generally comparable recov-
ry rates from studies using any of the rayon, calcium alginate
r Dacron swabs, suggest that in practice, the majority of swab
aterial currently used in NP studies will collect sufﬁcient bacte-
ia to be detected, and possible differences in the swab materials
ill most likely appear only in samples with very low yields of
rganisms.
Recently, ﬂockednylon swabshavebeen introduced into clinical
ractice, on the premise that the protruding nylon ﬁbres improve
he recovery of target organisms from the sampled surface, and
llow for the rapid elution of collected material into the transport
edium. There are no large published clinical studies comparing
ocked swabs and other swab types for the recovery of pneumo-
occi from the nasopharynx, although a study with spiked and2 (2014) 165–179 169
paired NP samples suggests that ﬂocked swabs are superior to
both Dacron and rayon [22], and clinical evidence from other types
of sampling (i.e. sampling for viral pathogen detection) indicates
that ﬂocked swabs are equivalent or superior to Dacron or rayon
swabs in proportion of positive specimens, and the quantity of
organism recovered [23–27]. Flocked swabs have been used in a
variety of large pneumococcal NP studies with high rates of col-
onization measured, supporting their use [28,29]. Since ﬂocked
swabs are made from inert nylon material, they are unlikely to
interfere with any culture or molecular assay. These swabs may
also result in higher yields of organisms which would improve
the sensitivity of detection, in particular from samples with low
density of carriage and minor serotypes. Note that collecting dual
swabs (where two swabs are twisted together and inserted into
onenostril) can beuseful for comparison studies. Unfortunately the
ﬂocked swabs that are currently on the market cannot be twisted
together.
5.1. Recommendation
NP swabs made from calcium alginate, rayon, Dacron or nylon
materials are suitable for culture based carriage studies to deter-
mine the circulating serotypes in a population. For molecular
analyses, synthetic materials such as nylon or Dacron are preferred
as theyare least likely to inhibit ampliﬁcationofDNA. Flockednylon
swabs are superior for the detection of other pathogens such as
respiratory viruses.
5.2. Future research
Clinical and laboratory studies to compare nylon ﬂocked swabs,
Dacron, rayon and calcium alginate in samples with low pathogen
concentrations, would be of value. Studies that include molecular
assays and a broad range of pathogen types would be optimal. Pro-
duction of ﬂocked swabs that can be divided in two may be useful
for comparison studies.
6. Swab transport and storage
STGG medium was previously recommended as a swab trans-
port and storagemedium [1] because it is non-proprietary, is easily
made with commonly available ingredients, is inexpensive and
had been successfully used by many groups investigating carriage
of pneumococci and other upper respiratory tract bacterial orga-
nisms. Interestingly, a recent study investigated NP carriage in 574
Nepalese children using two intertwined rayon swabs. They found
that the carriage prevalence was 41% with a NP swab that had been
stored in silica desiccant sachets for up to 2 weeks, compared with
59% with a NP swab that had been placed in STGG and processed
within 8h. Therewas 79% agreement between the twomethods. As
such, silicadesiccant sachetsmaybeusefulwhen there isdelayedor
limited access tomicrobiological facilities, although it likely results
in an underestimate of the carriage rate and may alter the serotype
and/or genotype distribution (David Murdoch, personal communi-
cation).
Therefore, although no systematic comparisons have been con-
ducted, consensus is that STGG remains the medium of choice for
transport and storage of NP swabs for the present time.
6.1. Sample collection medium
The STGG medium has been adapted from Gibson and Khoury
[30] and Gherna [31], and should be produced as described by
O’Brien et al. [32]. In brief, mix 2.0 g of skim milk powder, 3.0 g of
tryptone soy broth powder, 0.5 g of glucose, and 10ml of glycerol
and dissolve in 100ml of distilled water. The STGG medium should
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e autoclaved before use: dispense 1.0ml of STGG medium into
.5ml screw-capped vials and autoclave for 10min at 121 ◦C. STGG
ials can be stored frozen at −20 ◦C (or colder) or refrigerated until
se. A standard volume of 1.0ml is preferred to allow for compar-
sons across studies in quantiﬁcation of pneumococci. The volume
f STGG should be reported for all studies. Allow tubes of STGG
edium to reach room temperature before use. Usually the milk
olids pellet in the bottom of the tube is resuspended by vortex-
ng for 10–20 s, although there is no evidence that this is necessary
nd in practice this is not always done. Consensus is that STGG
edium should be used within 6 months of preparation whether
tored frozen or refrigerated. A quality control test for sterility of
he STGG medium must be performed on each batch. The ability of
TGG medium to support recovery of viable pneumococci should
lso be checked.
.2. Inoculation and transport
Immediately following sample collection the NP swab is asep-
ically placed into the room-temperature STGG, inserting it to the
ottom of the STGG medium, raising it slightly and cutting off the
haft with sterile scissors (to enable lid closure), leaving the swab
n the STGG media. The closed tube is then placed in a cool box or
n wet ice and transported to the laboratory within 8h. Once in the
aboratory, the specimen is vortexed at high speed for 10–20 s to
isperse organisms from the swab tip, and immediately processed
nd stored as described below.
.3. Processing and storage
To prevent sample loss in the event of freezer failure, we rec-
mmend dividing the vortexed specimen into two aliquots, one
f ∼0.2–0.3ml, and the second comprised of the remainder of the
TGG containing the swab. The two aliquots should preferably be
tored in separate freezers.
Several studies have investigated the impact of frozen stor-
ge (at −20 ◦C and ULT (ultra low temperature, −70 ◦C or colder))
n the recovery of upper respiratory tract bacterial pathogens
ncluding pneumococci in STGG medium over time [15,30,32–37].
hese studies have shown minimal or no signiﬁcant effects of
LT freezing. For example, Abdullahi et al. [15] reported that
ecovery of pneumococci by culture from fresh and frozen (ULT
or two months) NP swab samples in STGG was indistinguish-
ble, although there were differences in the serotype distribution
ecovered. This could be, at least in part, attributed to the
ifferential capacity of pneumococcal serotypes to survive the
reezing process. Kwambana et al. [35] investigated the differ-
nce between NP swabs stored in STGG and analyzed within
ours of collection, and those analyzed after 30 days of stor-
ge at ULT. 16S rRNA gene-based terminal restriction fragment
ength polymorphism and clone analysis showed that the mean
umber of operational taxonomic units (OTUs), a measure of over-
ll microbial diversity, decreased after frozen storage, although
he changes to the relative abundance of most species was min-
mal.
Long-term ULT storage has been evaluated with clinical [34]
r laboratory-prepared samples (T. Kaijalainen, unpublished data)
nding no demonstrable changes in semi-quantitative viability of
neumococcus over a 12 year period.
Our previous recommendations stated that STGG swabs could
e held at -20 ◦C for up to six weeks [1]. This recommendation was
ased on a relatively limited evidence base [32,33] and consensus
ractice. However, a recent publication found that the numbers
f culturable pneumococci declined within 24h at −20 ◦C [37],2 (2014) 165–179
suggesting that this temperaturemayonlybe suitable for very short
periods.
6.4. Recommendation
STGG is recommended as the primary transport and storage
medium. Specimen swabs should be transported on wet ice or
colder conditions during transport and handling, and be frozen
at ULT as soon as possible after collection. Storage at −20 ◦C is
acceptable if the specimen will be tested in the short term (within
days) but is not recommended for longer term storage. Investiga-
tors should consider dividing the original STGG specimen into two
or more aliquots and storing these in separate freezers.
6.5. Future research
Efﬁcacy of newer transport media to maintain microorgan-
ism viability at room temperature, cold or ULT storage of NP
swabs could be evaluated in ﬁeld settings. Future research should
assess the recovery of pneumococci after storage of different
aliquots of NP material in STGG medium in different storage
conditions, and the impact of long-term frozen storage of STGG
samples on the recovery of pneumococci for low-density speci-
mens, particularly to establish guidelines around −20 ◦C storage.
Finally, an assessment of limits of the duration of storage of
STGG medium prior to use, at various temperatures but especially
frozen, would assist sites with limited ability to produce STGG
themselves.
7. Culture for pneumococci
An ideal culture medium should prevent growth of non-
pneumococcal species without inhibiting growth of the pneumo-
cocci itself. To this end, deﬁbrinated blood agar (from a non-human
source such as sheep, horse or goat) supplemented with 5g/ml
gentamicin has been the most widely used selective medium to
culture pneumococci fromNP samples [38–40]. For culture of pedi-
atric NP and throat swabs, this medium has been shown to result
in a similar yield of pneumococci to anaerobically incubated blood
agar plates [41]. The concentration of gentamicin in agar has been
shown to have a signiﬁcant effect on isolation of pneumococci [42].
There are similar yields of pneumococci when culturing respira-
tory tract specimens onblood agar supplementedwith2.5–5g/ml
gentamicin comparedwith culture on plain blood agar or bymouse
inoculation [43–45]. Alternative supplements used to improve the
isolation of pneumococci by culture include combinations of col-
istin and nalidixic acid (CNA) or colistin and oxolinic acid (COBA)
[46]. Unlike blood agar-gentamicin andCOBA, blood-CNAagar does
not suppress the growth of staphylococci.
7.1. Recommendation
Blood agar, either Columbia or trypticase soy agar base with
sheep, horse, or goat blood, supplemented with 5g/ml genta-
micin is considered the core primary isolation media. Blood-CNA
or COBA agars are acceptable alternatives, whereas human blood
agar should never be used [45,47]. Thoroughly mix a fresh or
fully-thawed NP swab-STGG specimen using a vortex and inoc-
ulate 10l onto a selective plate and streak into all four plate
quadrants with sterile loops. Some investigators may choose to
use larger volumes of STGG medium (e.g. 50l or 100l). As this
will affect the sensitivity of detection, the volume used should
be noted when reporting. Incubate the pneumococcal plate(s)
overnight at 35–37 ◦C in a CO2 enriched atmosphere, either by
using a candle jar or 5–10% CO2 incubator. Plates with no growth
should be re-incubated for another 24h before being discarded
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s negative. If required, record the semi-quantitative growth of
lpha-hemolytic colonies [1]. Single colonies are then picked
nd subcultured for analysis, including identiﬁcation as described
elow.
.2. Future research
Culture of NP specimens, by scraping or drilling into the frozen
TGG media using a sterile microbiological loop, might permit
rolongation of specimen integrity. This technique has been used
uccessfully in the sub-culture of pneumococcal isolates stored in
TGG, but requires quantitative validation for usewith NP samples.
. Culture-based broth enrichment of nasopharyngeal
amples
Several investigators have applied a culture enrichment step
o samples in order to enhance the sensitivity of pneumococcal
dentiﬁcation and serotyping methods. For example, Kaltoft et al.
48] demonstrated that a serumbroth (beef infusion supplemented
ith horse serum and blood) improved the ability of traditional
ethods to detectmultiple serotypes. Similarly, Carvalho et al. [49]
ound that an enrichment step in Todd Hewitt broth supplemented
ith yeast extract and rabbit serum increased the proportion of
pecimens with pneumococcus identiﬁed, as well as increasing the
etection of multiple serotypes by culture and molecular methods.
However, there are some remaining concerns with broth
ulture-ampliﬁcation. The pneumococci may be overgrown by
ther species, and not all pneumococcal strains or serotypes grow
t the same rate in vitro [50–52]. Moreover, broth culture enrich-
ent may reduce detection of co-colonization of other species
53], or may not be appropriate for all sample types. In addition,
ome media components (such as animal serum) may be difﬁcult
o access in developing countries.
.1. Recommendation
There is insufﬁcient evidence to make a recommendation
egarding inclusion of a broth culture-based enrichment step for
hedetectionof pneumococci. Quantiﬁcationof pneumococcal load
houldnotbedeterminedusing samples thathaveundergonebroth
nrichment.
.2. Future research
Whole-genome ampliﬁcation methods may overcome lim-
tations of low amounts of DNA. It would be useful to
ptimize broth culture-ampliﬁcation (e.g. by including a selective
gent), and to test the effects of broth-culture ampliﬁcation on
ulture and molecular-based identiﬁcation and serotyping meth-
ds.
. Picking pneumococcal colonies for identiﬁcation and
erotyping
These recommendations establish the minimum set of crite-
ia to determine the presence of pneumococci, and the dominant
neumococcal serotype, in order to ascertain the prevalence of
neumococcal carriage and the serotypes present in the over-
ll population under study. Given this objective, there are two
ain issues to consider: how many colonies to pick, and how toelect them. Detecting multiple serotype carriage is important for
ome epidemiologic questions, but serotyping a few colonies is
n insensitive method to detect the true prevalence of multiple
erotype carriage [54–56]. For colony selection, the truly random2 (2014) 165–179 171
approach (e.g. where the STGG medium is diluted and spread on
agar plates to obtain single colonies, then all the colonies are
numbered and selected using a list of random numbers) may be
optimal statistically, but is considered impractical for routine use.
Choosing colonies based on morphology is more efﬁcient [54],
but leads to a bias towards detecting those that are morphologi-
cally distinct such as serotype 3 or nontypeable (NT) pneumococci
[57].
9.1. Recommendation
Select one colony from the selective plate. If more than one
morphology is present, this colony should be from the predom-
inant morphology. We also suggest that one colony from each
morphology be selected; however they should be recorded and
reported separately (e.g. subdominant 1, subdominant 2 in order
of prevalence). This allows for collection of information regarding
possible multiple serotype carriage, albeit in a biased fashion. If
there is only one morphology present, and it is later identiﬁed as
non-pneumococcus, return to the primary culture plate and repeat
colony selection at least once to verify that pneumococci are not
present.
10. Culture-based identiﬁcation of pneumococci
Traditionally, identiﬁcation of pneumococci has focused on iso-
lates cultured from normally sterile sites that tend to display a
classical phenotype, in particular being optochin susceptible and
bile soluble. These identiﬁcation criteria are generally satisfac-
tory for clinical application and are widely applied in diagnostic
microbiology. However, alternative pneumococcal forms are fre-
quently cultured from NP specimens [58,59]. These non-classical
formsmaygive test results normally expected for othermembersof
the viridans group of streptococci [60,61] and some other viridans
group streptococci have been reported to give test results normally
associated with pneumococci [62–64]. For example, the original
description of Streptococcus pseudopneumoniae was optochin sus-
ceptiblewhen grown in ambient air conditions, and resistantwhen
incubated in5%CO2 atmosphere [62].However, recent studieshave
found that these phenotypic characteristics are not universal for S.
pseudopneumoniae [65]. These issues create difﬁculties for identi-
ﬁcation and differentiation between pneumococci and other oral
streptococci in carriage studies.
10.1. Recommendation
Although optochin susceptibility and bile solubility are still
considered key tests, we recommend extending the criteria for
presumptive identiﬁcation of pneumococci to encompass non-
classical forms of pneumococci (Fig. 2). Further testing by a
reference laboratory may be needed if the research question
requires a more deﬁnitive identiﬁcation than this algorithm pro-
vides. We now recommend that all -hemolytic colonies growing
on selectivemedia are potentially analyzable, rather than just those
with ‘typical pneumococcal colony morphology’ [66], and reiterate
that the optochin test culture plate is incubated in 5% CO2 atmo-
sphere, rather than ambient air.
10.2. Future research
Further work is needed to more clearly differentiate pneumo-
cocci, particularly the non-classical forms, from other oral
microbes. As a clearer understanding of how to fully deﬁne the
species is achieved, a revised pragmatic deﬁnition of pneumococci
will be needed for use in carriage studies.
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12.3. New serotyping methodsneumococcus).
1. Non-culture based identiﬁcation
Non-culture based techniques have some advantages in detec-
ing pneumococci from NP samples: they do not require viable
rganisms, preserve the original composition of theNP sample and,
epending on the methods used, provide a detailed characteriza-
ion and quantiﬁcation of the pneumococci within a sample.
The detection of pneumococci in a NP swab by a non-culture
ethod is complicated by the intrinsic complexity of the sample,
he low numbers of pneumococci in the sample and by difﬁculties
n interpreting the epidemiological relevance when pneumococ-
al genetic material is detected in culture-negative samples. The
ample is a representation of the NP microbiome, which contains
umerous bacterial species [67] and may include close relatives of
neumococci such as S. pseudopneumoniae, Streptococcus mitis and
ther streptococcal species that also inhabit this niche [68].
The ideal method for non-culture identiﬁcation in NP swabs
hould unequivocally detect the pneumococcus with high sen-
itivity and speciﬁcity; it should also be rapid, easy to perform,
nexpensive, and deployable on a large scale. In the last decade,
everal non-culture methods aiming to detect pneumococci in
iological samples have been developed including PCR-based
trategies targeting speciﬁc DNA markers such as rpoA [69], sodA
70], tuf [71], recA [72], piaA [73], Spn9802 [74], ply [75], a 181-
p pneumococcal-speciﬁc fragment [76], 16S-rDNA [77], psaA [78],
nd lytA [79–81]. For many of these methods speciﬁcity prob-
ems have been detected [64,65,82,83]. For others, there has been
nsufﬁcient validation against diverse collections of close relatives
f pneumococci. In addition, there is an increasing body of more
ophisticated methods that, although promising, may not be easily
pplied in routine analysis of NP samples [84–87]. While there is
urrently no gold standard method for non-culture identiﬁcation
f pneumococci from NP swabs [63,88,89], the lytA real-time PCR
ssay described by Carvalho et al. [81] is widely used and appears
o be species-speciﬁc. However, given the capacity of pneumo-
occi to exchange genes with other oral streptococci [88,90] a
ultilocus approach such as used in multilocus sequence typingMLST), microarray or whole genome-sequencing may prove valu-
ble [64,91,92].2 (2014) 165–179
11.1. Recommendation
Culture should remain the gold standard for detection of
pneumococci in NP swab samples. Investigators may wish to
complement culture detection with a non-culture technique; the
method we currently recommend is lytA real-time PCR [81].
11.2. Future research
A systematic laboratory validation of non-culture methods
against large collections of nasopharyngeal and non-classical iso-
lates is needed to guide future recommendations. Studies that
are designed to determine the clinical relevance of pneumococcal
culture-negative but DNA-positive samples are needed.
12. Serotyping
12.1. Quellung
The current standard method for serotyping of pneumococcal
isolates is the capsular reaction/swelling test (Quellung reaction
or Neufeld test) [1]. The traditional method described by Lund
[93], Austrian [94] and the Statens Serum Institut [95] using ×100
magniﬁcation with oil immersion, is still widely used in Europe
and North America. In Australia and Papua New Guinea, the ‘dry’
method using ×40 magniﬁcation without oil [96] has been in use
since at least the 1970s (M. Gratten, personal communication). The
‘dry’ method is quicker and simpler than the ‘wet’ method using oil
immersion [97] but there is no evidence to suggest that onemethod
is superior to the other. Phase contrast microscopy improves the
visibility of the capsule, however it is not essential in conducting
the Quellung reaction.
Sincepublicationof ourprevious recommendation, 11European
reference laboratories participated in the validation of pneumococ-
cal serotyping [98]. A high degree of agreementwas found between
the Quellung test and other serotyping methods, including latex
agglutination and gel diffusion. Speciﬁcally, there was no signif-
icant difference in the percentage of mistypings (39 out of 735
serotypings) by the Quellung method (5.2%, six laboratories) com-
pared to the non-Quellung methods (5.7%, ﬁve laboratories) [98].
An inter-laboratory quality control program conducted in four lab-
oratories over ten years found a serotyping concordance of 95.8%
using Quellung [99]. Although costly and time-consuming, the
Quellung reaction may be preferred in laboratories with suitably
experienced staff and a comprehensive set of antisera.
12.2. Latex agglutination
Compared with Quellung, latex agglutination is less expen-
sive, easier to learn, and does not require a microscope. It may
therefore be more suitable for settings with limited budgets and
training capacity. Commercial reagents are available; alternatively
latex reagents can be produced and validated in-house. In the lat-
ter case antibodies from commercial antisera are passively bound
onto latex particles under aseptic conditions [100,101]. Latex
reagents produced in-house must undergo careful quality control.
Reagents are stored at 4 ◦C. As the long-term viability of these
reagents is unknown, they should be quality control tested at least
annually. Reactions should be conducted using reagents at room-
temperature, on a glass surface, using a consistent inoculum of
fresh, low passage pneumococci.Recently, a variety of new serotyping methods have been devel-
oped including phenotypic methods that rely on antigen detection,
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Table 3
Key advantages and disadvantages of selected serotyping methods.
Method Key advantages Key disadvantages Example references
Phenotypic detection
Quellung Gold standard Requires experience to interpret [1,2]
High sensitivity and speciﬁcity Typing sera are expensive
Latex agglutination High sensitivity and speciﬁcity Commercial latex reagents are expensive [3–5]
Relatively simple to interpret In-house latex reagents require extensive QC
Lab procedures to prevent
mis-interpretation of results needed
Dot blot Cost effective – uses highly diluted typing sera Lack of speciﬁcity through cross-reactions [6]
Interpretation is subjective
Requires signiﬁcant optimization for each
serotype
Microbead assays e.g. Flow
cytometry or Luminex
High throughput Expensive capital equipment [7–12]
Sensitivity and speciﬁcity similar to Gold standard methods May need expensive polyclonal typing serum
and serotype speciﬁc monoclonal antibodiesCan be designed to detect capsular polysaccharide, or PCR
products Technically demanding, particularly in assay
optimisation and set-up
Genotypic detection
Multiplex PCR Highly sensitive (although less than individual PCRs) Not quantitative [11,13–19]
Detection of non-viable organisms Risk of amplicon contamination
Can be coupled with different detection methods (e.g.
hybridisation, bead-based or mass-spectrometry)
Closely related serotypes cannot be
discriminated and are detected as a group
Technically straightforward
Widely used
Real-time PCR Extremely sensitive Closely related serotypes cannot be
discriminated and are detected as a group
[20,21], Paranhos-Baccalà
et al., unpublished dataDetection of non-viable organisms
Semi-quantitative
Microarray Large number of serotypes detected Expensive reagents and equipment required
Array can include targets for all serotypes, including virulence
factors and antimicrobial resistance markers
Operator needs a reasonably high level of
technical expertise, particularly for
interpretation of unusual ﬁndings
[3,22,23]
May be able to measure relative abundance
Can be difﬁcult to distinguish closely related
serotypes, although has capacity to include
multiple targets for each serotype.
Detection of non-viable organisms
Single PCR with
Sequencing
Only one primer set used May be difﬁcult to fully discriminate
between all serotypes
[24,25]
Detection of non-viable organisms
References: [1] Lund E. Laboratory diagnosis of Pneumococcus infections. Bull World Health Organ. 1960;23:5-13. [2] Hare KM, Smith-Vaughan H, Binks M, Park IH, Nahm
MH, Leach AJ. “Dodgy 6As”: differentiating pneumococcal serotype 6C from 6A by use of the Quellung reaction. J Clin Microbiol. 2009;47:1981-2. [3] Turner P, Hinds J, Turner
C, Jankhot A, Gould K, Bentley SD, et al. Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular
serotyping by microarray. J Clin Microbiol. 2011;49:1784-9. [4] Slotved HC, Kaltoft M, Skovsted IC, Kerrn MB, Espersen F. Simple, rapid latex agglutination test for serotyping
of pneumococci (Pneumotest-Latex). J Clin Microbiol. 2004;42:2518-22. [5] Ortika BD, Habib M, Dunne EM, Porter BD, Satzke C. Production of latex agglutination reagents for
pneumococcal serotyping. BMC Res Notes. 2013;6:49. [6] Fenoll A, Jado I, Vicioso D, Casal J. Dot blot assay for the serotyping of pneumococci. J Clin Microbiol. 1997;35:764-6.
[7] Sheppard CL, Harrison TG, Smith MD, George RC. Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-speciﬁc Streptococcus
pneumoniae antigen in urine samples. JMedMicrobiol. 2011;60:49-55. [8] CeyhanM, Yildirim I, Sheppard CL, George RC. Pneumococcal serotypes causing pediatricmeningitis
in Turkey: application of a new technology in the investigation of cases negative by conventional culture. Eur J Clin Microbiol Infect Dis. 2010;29:289-93. [9] Findlow H, Laher
G, Balmer P, Broughton C, Carrol ED, Borrow R. Competitive inhibition ﬂow analysis assay for the non-culture-based detection and serotyping of pneumococcal capsular
polysaccharide. Clin Vaccine Immunol. 2009;16:222-9. [10] Lal G, Balmer P, Stanford E, Martin S, Warrington R, Borrow R. Development and validation of a nonaplex assay for
the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J Immunol Methods. 2005;296:135-47. [11] Park MK, Briles DE, Nahm MH. A latex
bead-based ﬂow cytometric immunoassay capable of simultaneous typing of multiple pneumococcal serotypes (Multibead assay). Clin Diagn Lab Immunol. 2000;7:486-9.
[12] Yu J, Carvalho M da G, Beall B, Nahm MH. A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR. J Med Microbiol. 2008;57:171-8. [13]
Zhou F, Kong F, Tong Z, Gilbert GL. Identiﬁcation of less-common Streptococcus pneumoniae serotypes by a multiplex PCR-based reverse line blot hybridization assay. J Clin
Microbiol. 2007;45:3411-5. [14] Kong F, Brown M, Sabananthan A, Zeng X, Gilbert GL. Multiplex PCR-based reverse line blot hybridization assay to identify 23 Streptococcus
pneumoniae polysaccharide vaccine serotypes. J Clin Microbiol. 2006;44:1887-91. [15] Yu J, Lin J, Kim KH, Benjamin WH, Jr., Nahm MH. Development of an automated and
multiplexed serotyping assay for Streptococcus pneumoniae. Clin Vaccine Immunol. 2011;18:1900-7. [16] Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for
determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44:124-31. [17] Saha SK, Darmstadt GL, Baqui AH, Hossain B, Islam M, Foster
D, et al. Identiﬁcation of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: implication for surveillance and vaccine design. PLoS ONE.
2008;3:e3576. [18] Rivera-Olivero IA, Blommaart M, Bogaert D, Hermans PW, de Waard JH. Multiplex PCR reveals a high rate of nasopharyngeal pneumococcal 7-valent
conjugate vaccine serotypes co-colonizing indigenous Warao children in Venezuela. J Med Microbiol. 2009;58:584-7. [19] Massire C, Gertz RE, Jr., Svoboda P, Levert K, Reed
MS, Pohl J, et al. Concurrent serotyping and genotyping of pneumococci by use of PCR and electrospray ionization mass spectrometry. J Clin Microbiol. 2012;50:2018-25.
[20] Azzari C, Moriondo M, Indolﬁ G, Cortimiglia M, Canessa C, Becciolini L, et al. Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children
with culture negative pneumococcal invasive disease. PLoS ONE. 2010;5:e9282. [21] Pimenta FC, Roundtree A, Soysal A, Bakir M, du Plessis M, Wolter N, et al. Sequential
triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden. J Clin Microbiol. 2012. [22] Tomita Y, Okamoto
A, Yamada K, Yagi T, Hasegawa Y, Ohta M. A new microarray system to detect Streptococcus pneumoniae serotypes. J Biomed Biotechnol. 2011:352736. [23] Wang Q, Wang
M, Kong F, Gilbert GL, Cao B, Wang L, et al. Development of a DNA microarray to identify the Streptococcus pneumoniae serotypes contained in the 23-valent pneumococcal
polysaccharide vaccine and closely related serotypes. J Microbiol Methods. 2007;68:128-36. [24] Leung MH, Bryson K, Freystatter K, Pichon B, Edwards G, Charalambous BM,
et al. Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy. J Clin Microbiol. 2012;50:2419-27. [25] Elberse KE, van de Pol I, Witteveen S,
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nd those that are genotype based. Several of these new meth-
ds are summarized in Table 3. Examples of genotypic methods
nclude microarray [102–105], single or multiplex real-time PCR
[106,107], Paranhos-Baccalà et al., unpublished data), single-
lex PCR combined with sequencing [108,109] and multiplex PCR
110–112].Multiplex PCRproducts are usually detected by gel elec-
rophoresis, but may also be detected by mass-spectrometry [113],
NA hybridization [114,115] or automated ﬂuorescent capillary
lectrophoresis [116] for example. Phenotypicmethods include the
otblot assay [117,118], latexagglutination (seeSectionabove) and
ead-based assays on aﬂow-cytometry or Luminex-basedplatform
119–124].
In general, methods that involve antibody-antigen reactions
re prone to cross reactivity although this is reduced where a
igniﬁcant amount of bound antibody is required for serotype
dentiﬁcation, such as capsule swelling reactions (Quellung), or
n methods that involve quantitative detection of bound antibody
ﬂow-cytometry or Luminex) [123,125]. Improvements to these
ethods can be made through the absorption of non-speciﬁc reac-
ive antibodies [117] and the use of monoclonal antibodies [124].
n the case of genotype detection, the primary limitations are the
equencediversity of the capsular loci,which can lead to targetmis-
atches, and the inability to discriminate between closely related
erotypes. The continued production of new sequence data should
esult in better target selection and primer/probe design that can
roduce results with similar sensitivity and speciﬁcity to the gold
tandard methods.
For pure pneumococcal cultures, many methods are valid, and
hemost appropriate onewill depend on the study setting. As such,
e do not recommend a particular method over another, except to
ote that theparticularmethod’s performance should be rigorously
alidated against the Quellung test.
Serotyping pneumococci directly from the NP sample is more
hallenging. As mentioned in Section 11, pneumococci may be
resent in low numbers (leading to low sensitivity), and/or as a
mall proportion of theNP cells (i.e. comparedwith cells fromother
rganisms or the host), leading to low speciﬁcity. Divergent homo-
ogues of pneumococcal capsular genes also have been found in
on-pneumococcal species [126]. Furthermore, the clinical rele-
ance of identifying serotype-speciﬁc DNA in a culture-negative
ample is not known.
2.4. Recommendation
Serotyping of pure pneumococcal isolates using Quellung by
he wet or dry method is considered the core method. Latex
gglutination serotyping may also be used. Many new serotyping
ethods are being developed, and although some may be valid
here is currently insufﬁcient evidence to provide recommenda-
ions. Serotyping directly from the NP specimen is insufﬁciently
eveloped to recommend as a core method.
2.5. Future research
Assessment of the assay and clinical performance of new
erotyping methods, particularly when testing directly from the
P sample is needed.
3. Multiple serotype carriage
Carriage of multiple pneumococcal serotypes is relatively
ommon, particularly in areas where the carriage rate and dis-
ase burden are high [54,112,127,128]. Multiple carriage usually
nvolves carriage of a major serotype, together with one or more
inor serotype populations. Although it is clear that standard
erotyping methods underestimate multiple carriage [49,55], the2 (2014) 165–179
clinical and public health relevance of multiple carriage is less
well established. Theoretically, detection of minor serotypes may
help to predict the shift in serotype distribution through serotype
replacement following pneumococcal vaccination, particularly in
highburdensettings [129], andallowabetterunderstandingofhow
epidemic serotypes emerge in some populations. Recent data using
new serotyping methods suggest that the impact of vaccination on
multiple serotype carriage may be complex [87,130].
To some extent, our understanding is limited by the methods
used to detect and characterize multiple carriage. Ideally, a new
method should detect multiple serotypes directly from the spec-
imen (i.e., without a culture step which may alter the relative
proportions of various strains) without false positive reactions,
and be quantitative, affordable, practical and capable of detec-
ting all known serotypes. Although many potential methods have
recently been developed they have not been sufﬁciently validated.
The PneuCarriage project has compared 20 serotyping methods
from 15 research groups, including their ability to detect multi-
ple serotype carriage, using a well-characterized reference bank
of samples (Satzke et al., manuscript in preparation). This project
will provide further information on suitable methods for detecting
multiple serotype carriage with high sensitivity and speciﬁcity.
13.1. Recommendation
Current methods routinely underestimate the prevalence of
multiple serotype carriage. Although many new techniques are
in development, there is insufﬁcient evidence to make a rec-
ommendation. For studies where multiple carriage is relevant,
we recommend retaining the original STGG specimens for future
assessment when optimal methods are deﬁned.
13.2. Future research
A thorough comparison of methods to detect NP carriage of
multiple pneumococcal serotypes frompneumococcal cultures and
directly from specimens is needed. The clinical and public health
importance of multiple serotype carriage needs to be determined.
14. Storage and recovery of isolates
Several storage methods, such as lyophilization, or ULT storage
on commercially available chemically-treated beads, are appropri-
ate for long-term storage of pure pneumococcal isolates. However,
our recommendations for storageof pneumococcal isolates in STGG
media are consistent with the 2003 methods [1], but with some
minor amendments to reﬂect the breadth of consensus practice.
14.1. Recommendation
The storage of at least one tube of each pneumococcal isolate is
recommended. To do this inoculate (using a swab or loop) a fresh,
overnight, pure lawn culture into suitable media, such as STGG,
under aseptic conditions. After ensuring the growth is homoge-
nized, for example by a short vortex step, freeze at ULT. Short-term
storage (<12 months) of these high-titer stocks at −20 ◦C in a non-
defrosting freezer is acceptable, although survival will decrease
over this time [33,37].
To recover the isolate, a small amount of frozen material can be
scraped from the surface of the STGGmedium, or the entire volume
thawed and an aliquot taken. The scraping or aliquot is then usually
inoculated onto solid medium to check for purity of the isolate.
Recovery of isolates should be undertaken aseptically, with a view
to minimizing temperature ﬂuctuations of the stored isolate by, for
example, keeping tubes on dry-ice (or if necessary, and for short
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eriods, wet ice) when handling them, and only processing a few
ubes at a time.
4.2. Future research
Investigation of the effect of vortexing and frozen storage on
ecovery, identiﬁcation (e.g. optochin susceptibility) and serotyp-
ng (e.g. production of capsule) is needed. The performance of
impler storage media could be validated.
5. Shipping of isolates
There aremanymethods available for shippingofpneumococcal
solates. These include using STGG, silica gel desiccant sachets (sta-
le for a fortnight at room-temperature or amonth at 4 ◦C [66,131]),
orset media, Amies transport media, chocolate or similar agar
lopes, or lyophilization. There is no evidence base for preferring
ne method over another.
5.1. Recommendation
Any of the methods outlined above, or others that are shown to
e equally as effective are acceptable.
5.2. Future research
Comparison of effectiveness of different transport methods
ould be undertaken, although it is likely that many would prove
atisfactory.
6. Epidemiological role of carriage studies
In previous sections we have provided a core methodology to
erform pneumococcal NP carriage studies. We now consider the
ole of these carriage studies, especially in the context of pneumo-
occal disease control.
Signiﬁcant attention is being directed to whether and how NP
tudies of pneumococcal ecology in communities can be used to
nfer or predict disease impact. As the understanding of the quanti-
ative relationship between colonization and disease matures, the
ole of NP colonization outcomes as a tool for evaluating the global
ollout of PCV and other pneumococcal vaccines could become
ore central. The gold standard for such assessments has to date
een population-based surveillance of invasive pneumococcal dis-
ase (IPD) as exempliﬁed by the Active Bacterial Core Surveillance
f the Centers for Disease control in the USA [132]. This requires a
igniﬁcant clinical and diagnostic microbiology infrastructure, not
resent inmanydeveloping countries. Further, the collection of IPD
solates requires a clinical environment in which the great major-
ty of suspected cases of meningitis receive a lumbar puncture,
nd a sufﬁcient number of blood cultures are taken to recognize
n impact of PCV, given that blood culture will detect only 2–3%
f pediatric pneumonias prevented by PCV [133]. An alternate to
PD surveillance is syndromic surveillance for changes in pneu-
onia hospitalization or death following PCV introduction. These
ypes of studies have relied on large networks of electronic surveil-
ance [134] not available in developing countries, and can measure
nly the aggregate effect of a reduction in vaccine type disease and
eplacement. While such an approach based on just one or a few
ospitals may be possible, this depends on the care-seeking behav-
or of those most at risk for serious morbidity and mortality [135];
n many settings those are the very children with least access to
he health facility study sites. There are also considerable varia-
ions in thenumbers of cases over timedependingon comorbidities
uch as the severity of the inﬂuenza season [134] and the impact2 (2014) 165–179 175
of antiretroviral rollout if HIV is a signiﬁcant risk for pneumonia
hospitalization in the community [136]. Thus these studies are not
likely to be a primary strategy to detect the impact of PCVs and
when undertaken are at risk of being confounded by changes in
pneumonia burden or mortality trends unrelated to pneumococcal
disease (e.g. respiratory viral epidemics, malaria).
The assessment of carriage of vaccine type andnon-vaccine type
pneumococci is a direct, pathogen-speciﬁc measure of PCV impact
that is an indicator of the success or failure of a PCV rollout program
[129]. Cross sectional studies of carriage in the target age group of
PCV, as well as in older children and adults, will give a measure
of herd protection. Detection of important serotypes in develop-
ing countries (such as type 1) may still be done in carriage studies
if the subjects are carefully chosen, by including the detection of
carriage in subjects with pneumonia on arrival at health care facil-
ities. Detection of such rarely carried types in pneumonia patients
may reﬂect an etiological role of those types in pneumonia [137].
Carriage studies focused on young children with respiratory illness
will identify the group at risk for pneumococcal disease but also
provide access to older siblings who are often transmitters of the
pathogen, and mothers who may be key to measurement of herd
protection in adults. Cross sectional studies may detect changes
in the distribution of vaccine type carriage as soon as a year post
PCV introduction if sample size is sufﬁcient, with detection of pro-
found changes in distribution and herd protection, if present, by
3–4 years post PCV [138]. While carriage studies will not likely be
a direct measure of reduction in disease burden due to PCV, they
offer a direct measure of program effectiveness and the nature of
replacing pathogens, including an assessment of the impact of PCV
on the NP microbiome.
There are emerging data suggesting that quantitative detection
of carriage using microbiological methods, but also more easily
by quantitative PCR, may be diagnostic of pneumonia in adults
[139]. These methods may also reﬂect co-infection with respira-
tory viruses in children [140] which may be a signiﬁcant risk for
pneumonia hospitalization [141]. The antimicrobial susceptibility
proﬁle of carried pneumococci may be used to inform treatment
algorithms forpneumococcaldisease indevelopingcountries [142].
Quantitative molecular methods may increase the sensitivity of
detection of pneumococcal carriage, and may also detect more
easily than culture an impact of PCV on density of carriage. The
detection of serotypes in carriage can be used together with the
global distribution of those types in IPD [143] to develop an inva-
siveness index that may be predictive of the likelihood of invasive
disease replacement due to emerging types detected in carriage.
There are advances inwork linking theNP and IPD post-PCV impact
results, thereby providing a means to predict IPD impact using NP
carriage [147].
Carriage studies are also important for the assessment of the
serotype-speciﬁc basic reproductive number (R0) of the pneu-
mococcus in developing countries; whole genome sequencing of
carriage strains pre- and post-PCV introduction in developing
countries may give insight into the evolution of this pathogen in
response to PCV. The human is the natural reservoir of the pneumo-
coccus and more studies are needed on a human challenge model
[144].
The pathway for licensure of novel pneumococcal vaccines such
as those using pneumococcal proteins as conjugates, proteins given
with existing formulations of PCV, protein alone or killedwhole cell
vaccine will depend in large part on proof-of-principle for impact
on pneumonia or ability to induce herd protection by the demon-
strationof an impact on carriage.We speculate that carriage studies
will likely be central to the further development and licensure of
these novel vaccines [145].
There are few data on the sensitivity of culture to detect pneu-
mococcal carriage. Demonstration of carriage may increasingly be
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erformed using molecular techniques such as quantitative PCR,
icroarray, or mass spectrometry based methods. The expression
roﬁle of pneumococci in carriage may differ from pneumococci
nvading the host, as may the host proteomic response to carriage
r disease.
It is likely that future carriage studies will increasingly use
olecular methods to detect carriage including analysis of gene
xpression, density of carriage and impact on the microbiome.
arriage detection should be an essential part of assessing novel
neumococcal vaccines, and measuring the impact and safety of
CV or other pneumococcal vaccines on human populations.
7. Conclusions
These WHO core methods provide an update on the options
vailable and recommended approaches for studies of pneumococ-
al carriage. The consistent application of these methods in studies
ill provide the best opportunity to ensure that any observed
ifferences in colonization are not confounded by differences in
he specimen collection, handling or laboratory methods. A recent
ssessment of adherence to the coremethods in publishedNP stud-
es indicates that somebutnotall of the recommendationsarebeing
ully adopted [146]. As evidenced in this update, for some aspects
f the recommended method there are few appropriately designed
omparative studies to make deﬁnitive statements on preference.
n these situations, bestpractice is to somedegreeamatterof expert
pinion, ﬁeld experience and a reﬂection of imperfect data. For
tudy sites that have ongoingNP colonization studies, investigators
ay decide that consistency in methods over time is more impor-
ant than modifying their methods now to those recommended
ere. In such cases a bridging study comparing the results of NP
olonization using existing and the core methods would help to
larify the degree to which study ﬁndings are modiﬁed by the cho-
en methods. Notwithstanding these limitations, the application of
hese core methods allows researchers around the world to have
onﬁdence in carriage study results, and allows them to contribute
o our understanding of the pneumococcus and its control through
accines.
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